The biological conservation between fungi and mammals has made development of selective antifungal drugs a difficult challenge. Further complicating this situation is the selection of antifungal drug-resistant organisms during drug treatment. The pathogenic yeast Nakaseomyces glabratus (called here ...
ORGANISM(S): [Candida] glabrata CBS 138